Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-02-13

AUTHORS

Rosa Cámara, Eva Venegas, Juan Antonio García-Arnés, Fernando Cordido, Javier Aller, M. Luz Samaniego, Nuria Mir, Laura Sánchez-Cenizo

ABSTRACT

PurposeThe burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly patients in the real-world clinical practice setting in Spain.MethodsMulticenter, observational, descriptive, cross-sectional study in patients with acromegaly treated with pegvisomant for at least 12 months. Patient adherence was indirectly determined by Batalla and Haynes-Sackett questionnaires and directly by prescription record review. Additionally, treatment satisfaction was assessed by the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) and treatment convenience by an ad-hoc Pegvisomant questionnaire. Errors in reconstitution and administration process were determined by direct observation.Results108 patients were included in the analysis. Rates of adherence varied from 60.7 to 92.1% and did not correlate with disease control. Older patient age and alternative schedules other than daily pegvisomant dosing were associated with lower adherence. Treatment satisfaction and convenience was high, with a mean (SD) total SATMED-Q score of 74.6 ± 15.4 over 100 and a total ad-hoc Pegvisomant questionnaire score of 71.2 ± 15.2 over 100. 34.3% of patients made mistakes during the reconstitution /administration process.ConclusionsPatient adherence to pegvisomant was high (60.7–92.1%), but more than a third of the patients in the study made mistakes during the administration process, with a potential impact on disease control. Besides dosing compliance, correct administration of medication should be carefully assessed in these patients. More... »

PAGES

137-145

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11102-019-00943-1

DOI

http://dx.doi.org/10.1007/s11102-019-00943-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112095912

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30756345


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acromegaly", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Sectional Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human Growth Hormone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital Universitario y Polit\u00e9cnico La Fe, Avenida de Fernando Abril Martorell, 106, 46026, Valencia, Spain", 
          "id": "http://www.grid.ac/institutes/grid.84393.35", 
          "name": [
            "Hospital Universitario y Polit\u00e9cnico La Fe, Avenida de Fernando Abril Martorell, 106, 46026, Valencia, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "C\u00e1mara", 
        "givenName": "Rosa", 
        "id": "sg:person.01271623526.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271623526.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario Virgen del Roc\u00edo, Avenida Manuel Siurot, s/n, 41013, Sevilla, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411109.c", 
          "name": [
            "Hospital Universitario Virgen del Roc\u00edo, Avenida Manuel Siurot, s/n, 41013, Sevilla, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Venegas", 
        "givenName": "Eva", 
        "id": "sg:person.0773576715.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773576715.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Regional Universitario Carlos Haya, Avenida de Carlos Haya, 29006, M\u00e1laga, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411457.2", 
          "name": [
            "Hospital Regional Universitario Carlos Haya, Avenida de Carlos Haya, 29006, M\u00e1laga, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garc\u00eda-Arn\u00e9s", 
        "givenName": "Juan Antonio", 
        "id": "sg:person.01000242144.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000242144.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Complejo Hospitalario Universitario A Coru\u00f1a, As Xubias, 84, 15006, La Coru\u00f1a, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411066.4", 
          "name": [
            "Complejo Hospitalario Universitario A Coru\u00f1a, As Xubias, 84, 15006, La Coru\u00f1a, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cordido", 
        "givenName": "Fernando", 
        "id": "sg:person.01146401445.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146401445.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario Puerta de Hierro-Majadahonda, Calle Manuel de Falla, 1, 28222, Majadahonda, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.73221.35", 
          "name": [
            "Hospital Universitario Puerta de Hierro-Majadahonda, Calle Manuel de Falla, 1, 28222, Majadahonda, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aller", 
        "givenName": "Javier", 
        "id": "sg:person.01276230215.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276230215.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "TFS Statistical Services, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "TFS Statistical Services, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Samaniego", 
        "givenName": "M. Luz", 
        "id": "sg:person.010075630453.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010075630453.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pfizer S.L.U, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.424551.3", 
          "name": [
            "Pfizer S.L.U, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mir", 
        "givenName": "Nuria", 
        "id": "sg:person.01207611143.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207611143.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pfizer S.L.U, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.424551.3", 
          "name": [
            "Pfizer S.L.U, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "S\u00e1nchez-Cenizo", 
        "givenName": "Laura", 
        "id": "sg:person.01336274741.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336274741.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2466-11-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015827023", 
          "https://doi.org/10.1186/1471-2466-11-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11102-015-0691-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003872791", 
          "https://doi.org/10.1007/s11102-015-0691-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/jhh.2015.86", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028297512", 
          "https://doi.org/10.1038/jhh.2015.86"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-015-0266-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033117081", 
          "https://doi.org/10.1007/s12325-015-0266-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40618-017-0614-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083698903", 
          "https://doi.org/10.1007/s40618-017-0614-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11102-016-0754-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040188727", 
          "https://doi.org/10.1007/s11102-016-0754-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1009965803750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032354814", 
          "https://doi.org/10.1023/a:1009965803750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11102-013-0544-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021018318", 
          "https://doi.org/10.1007/s11102-013-0544-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02599549", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030047977", 
          "https://doi.org/10.1007/bf02599549"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-02-13", 
    "datePublishedReg": "2019-02-13", 
    "description": "PurposeThe burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly patients in the real-world clinical practice setting in Spain.MethodsMulticenter, observational, descriptive, cross-sectional study in patients with acromegaly treated with pegvisomant for at least 12 months. Patient adherence was indirectly determined by Batalla and Haynes-Sackett questionnaires and directly by prescription record review. Additionally, treatment satisfaction was assessed by the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) and treatment convenience by an ad-hoc Pegvisomant questionnaire. Errors in reconstitution and administration process were determined by direct observation.Results108 patients were included in the analysis. Rates of adherence varied from 60.7 to 92.1% and did not correlate with disease control. Older patient age and alternative schedules other than daily pegvisomant dosing were associated with lower adherence. Treatment satisfaction and convenience was high, with a mean (SD) total SATMED-Q score of 74.6\u2009\u00b1\u200915.4 over 100 and a total ad-hoc Pegvisomant questionnaire score of 71.2\u2009\u00b1\u200915.2 over 100. 34.3% of patients made mistakes during the reconstitution /administration process.ConclusionsPatient adherence to pegvisomant was high (60.7\u201392.1%), but more than a third of the patients in the study made mistakes during the administration process, with a potential impact on disease control. Besides dosing compliance, correct administration of medication should be carefully assessed in these patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11102-019-00943-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1119029", 
        "issn": [
          "1386-341X", 
          "1573-7403"
        ], 
        "name": "Pituitary", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "treatment satisfaction", 
      "real-world clinical practice", 
      "Disease Control", 
      "older patient age", 
      "daily subcutaneous administration", 
      "rate of adherence", 
      "cross-sectional study", 
      "acromegaly patients", 
      "patient age", 
      "patient adherence", 
      "record review", 
      "Medicines Questionnaire", 
      "treatment convenience", 
      "treatment adherence", 
      "subcutaneous administration", 
      "low adherence", 
      "questionnaire scores", 
      "patients", 
      "clinical practice", 
      "pegvisomant", 
      "correct administration", 
      "adherence", 
      "acromegaly", 
      "total AD", 
      "administration process", 
      "alternative schedules", 
      "administration", 
      "questionnaire", 
      "scores", 
      "MethodsMulticenter", 
      "SATMED", 
      "medications", 
      "dosing", 
      "study", 
      "satisfaction", 
      "months", 
      "reconstitution", 
      "age", 
      "treatment", 
      "burden", 
      "control", 
      "third", 
      "potential impact", 
      "review", 
      "compliance", 
      "schedule", 
      "rate", 
      "AD", 
      "convenience", 
      "practice", 
      "Spain", 
      "direct observation", 
      "impact", 
      "analysis", 
      "observations", 
      "process", 
      "mistakes", 
      "batalla", 
      "error", 
      "chronic daily subcutaneous administration", 
      "Haynes-Sackett questionnaires", 
      "prescription record review", 
      "Pegvisomant questionnaire", 
      "daily pegvisomant dosing", 
      "pegvisomant dosing", 
      "mean (SD) total SATMED", 
      "total SATMED", 
      "Pegvisomant questionnaire score", 
      "ConclusionsPatient adherence", 
      "PEGASO study"
    ], 
    "name": "Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study", 
    "pagination": "137-145", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112095912"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11102-019-00943-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30756345"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11102-019-00943-1", 
      "https://app.dimensions.ai/details/publication/pub.1112095912"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_808.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11102-019-00943-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11102-019-00943-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11102-019-00943-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11102-019-00943-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11102-019-00943-1'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      22 PREDICATES      117 URIs      100 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11102-019-00943-1 schema:about N1118af5e0a194c21b3370556527bd8eb
2 N1a9ab14608e6480a9d80749646b2e163
3 N1db51da34fd141fab325c59e50e652e6
4 N1f9b936499c343e8ae7346e08b8a30f7
5 N270f6d515b314827b99eb93f0ad4356a
6 N42fd54af77624c689306aab8081d4840
7 N770dcff01fd1422bb35c8310dd431a3f
8 N8f9d570379a84d489c70f61f3685c691
9 N93438e9b69e9486685cf52b097870462
10 Na9f62f3899204c0cb707cfb8a0b6dbcc
11 Nc13a7db43329442e96d762bb856fe787
12 Nca1b7dd59d984e6190c1c611217677a4
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author Nae91c678731f426998bf5ddc1932a6f8
16 schema:citation sg:pub.10.1007/bf02599549
17 sg:pub.10.1007/s11102-013-0544-7
18 sg:pub.10.1007/s11102-015-0691-0
19 sg:pub.10.1007/s11102-016-0754-x
20 sg:pub.10.1007/s12325-015-0266-5
21 sg:pub.10.1007/s40618-017-0614-1
22 sg:pub.10.1023/a:1009965803750
23 sg:pub.10.1038/jhh.2015.86
24 sg:pub.10.1186/1471-2466-11-6
25 schema:datePublished 2019-02-13
26 schema:datePublishedReg 2019-02-13
27 schema:description PurposeThe burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly patients in the real-world clinical practice setting in Spain.MethodsMulticenter, observational, descriptive, cross-sectional study in patients with acromegaly treated with pegvisomant for at least 12 months. Patient adherence was indirectly determined by Batalla and Haynes-Sackett questionnaires and directly by prescription record review. Additionally, treatment satisfaction was assessed by the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) and treatment convenience by an ad-hoc Pegvisomant questionnaire. Errors in reconstitution and administration process were determined by direct observation.Results108 patients were included in the analysis. Rates of adherence varied from 60.7 to 92.1% and did not correlate with disease control. Older patient age and alternative schedules other than daily pegvisomant dosing were associated with lower adherence. Treatment satisfaction and convenience was high, with a mean (SD) total SATMED-Q score of 74.6 ± 15.4 over 100 and a total ad-hoc Pegvisomant questionnaire score of 71.2 ± 15.2 over 100. 34.3% of patients made mistakes during the reconstitution /administration process.ConclusionsPatient adherence to pegvisomant was high (60.7–92.1%), but more than a third of the patients in the study made mistakes during the administration process, with a potential impact on disease control. Besides dosing compliance, correct administration of medication should be carefully assessed in these patients.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N306a8a12f8d94475a8e9b341bc78f3aa
32 Nd99d0ce7d4cc4a19a84985ef76f8dda9
33 sg:journal.1119029
34 schema:keywords AD
35 ConclusionsPatient adherence
36 Disease Control
37 Haynes-Sackett questionnaires
38 Medicines Questionnaire
39 MethodsMulticenter
40 PEGASO study
41 Pegvisomant questionnaire
42 Pegvisomant questionnaire score
43 SATMED
44 Spain
45 acromegaly
46 acromegaly patients
47 adherence
48 administration
49 administration process
50 age
51 alternative schedules
52 analysis
53 batalla
54 burden
55 chronic daily subcutaneous administration
56 clinical practice
57 compliance
58 control
59 convenience
60 correct administration
61 cross-sectional study
62 daily pegvisomant dosing
63 daily subcutaneous administration
64 direct observation
65 dosing
66 error
67 impact
68 low adherence
69 mean (SD) total SATMED
70 medications
71 mistakes
72 months
73 observations
74 older patient age
75 patient adherence
76 patient age
77 patients
78 pegvisomant
79 pegvisomant dosing
80 potential impact
81 practice
82 prescription record review
83 process
84 questionnaire
85 questionnaire scores
86 rate
87 rate of adherence
88 real-world clinical practice
89 reconstitution
90 record review
91 review
92 satisfaction
93 schedule
94 scores
95 study
96 subcutaneous administration
97 third
98 total AD
99 total SATMED
100 treatment
101 treatment adherence
102 treatment convenience
103 treatment satisfaction
104 schema:name Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study
105 schema:pagination 137-145
106 schema:productId N0b8303a46df549409ee18eb0a0008113
107 N3935f4dafb6b43bc804417b63b7e9c8c
108 Ndcb7c6a2e98b49e3bd0ee94fc19d767d
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112095912
110 https://doi.org/10.1007/s11102-019-00943-1
111 schema:sdDatePublished 2021-12-01T19:45
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N1032ddaea72a44d6988468076cba62d4
114 schema:url https://doi.org/10.1007/s11102-019-00943-1
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0b8303a46df549409ee18eb0a0008113 schema:name pubmed_id
119 schema:value 30756345
120 rdf:type schema:PropertyValue
121 N1032ddaea72a44d6988468076cba62d4 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N1118af5e0a194c21b3370556527bd8eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Adult
125 rdf:type schema:DefinedTerm
126 N1a9ab14608e6480a9d80749646b2e163 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Spain
128 rdf:type schema:DefinedTerm
129 N1db51da34fd141fab325c59e50e652e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Surveys and Questionnaires
131 rdf:type schema:DefinedTerm
132 N1f9b936499c343e8ae7346e08b8a30f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Male
134 rdf:type schema:DefinedTerm
135 N270f6d515b314827b99eb93f0ad4356a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Acromegaly
137 rdf:type schema:DefinedTerm
138 N2e77b17c8fec4e79a28800d0a9befd99 rdf:first sg:person.01000242144.43
139 rdf:rest Nb9eaf83b48344ceb923bf91e637d4537
140 N306a8a12f8d94475a8e9b341bc78f3aa schema:issueNumber 2
141 rdf:type schema:PublicationIssue
142 N3935f4dafb6b43bc804417b63b7e9c8c schema:name doi
143 schema:value 10.1007/s11102-019-00943-1
144 rdf:type schema:PropertyValue
145 N42fd54af77624c689306aab8081d4840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Multicenter Studies as Topic
147 rdf:type schema:DefinedTerm
148 N770dcff01fd1422bb35c8310dd431a3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Human Growth Hormone
150 rdf:type schema:DefinedTerm
151 N77f9754b3d9647c78e2152c8c4184574 rdf:first sg:person.01336274741.17
152 rdf:rest rdf:nil
153 N8f9d570379a84d489c70f61f3685c691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Middle Aged
155 rdf:type schema:DefinedTerm
156 N93438e9b69e9486685cf52b097870462 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Female
158 rdf:type schema:DefinedTerm
159 N99651a1b43404588a0f559ee2599d4d0 rdf:first sg:person.0773576715.92
160 rdf:rest N2e77b17c8fec4e79a28800d0a9befd99
161 Na9f62f3899204c0cb707cfb8a0b6dbcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 Nae91c678731f426998bf5ddc1932a6f8 rdf:first sg:person.01271623526.33
165 rdf:rest N99651a1b43404588a0f559ee2599d4d0
166 Nb49baa19bb0349c6ac6b9b05e28217ac rdf:first sg:person.01207611143.70
167 rdf:rest N77f9754b3d9647c78e2152c8c4184574
168 Nb9eaf83b48344ceb923bf91e637d4537 rdf:first sg:person.01146401445.26
169 rdf:rest Ne4b58d0a5c264885819f157500fb5704
170 Nc13a7db43329442e96d762bb856fe787 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Aged
172 rdf:type schema:DefinedTerm
173 Nca1b7dd59d984e6190c1c611217677a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Cross-Sectional Studies
175 rdf:type schema:DefinedTerm
176 Ncd8d1034c29447feaafc7b67bdf9586c rdf:first sg:person.010075630453.63
177 rdf:rest Nb49baa19bb0349c6ac6b9b05e28217ac
178 Nd99d0ce7d4cc4a19a84985ef76f8dda9 schema:volumeNumber 22
179 rdf:type schema:PublicationVolume
180 Ndcb7c6a2e98b49e3bd0ee94fc19d767d schema:name dimensions_id
181 schema:value pub.1112095912
182 rdf:type schema:PropertyValue
183 Ne4b58d0a5c264885819f157500fb5704 rdf:first sg:person.01276230215.08
184 rdf:rest Ncd8d1034c29447feaafc7b67bdf9586c
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
189 schema:name Clinical Sciences
190 rdf:type schema:DefinedTerm
191 sg:journal.1119029 schema:issn 1386-341X
192 1573-7403
193 schema:name Pituitary
194 schema:publisher Springer Nature
195 rdf:type schema:Periodical
196 sg:person.01000242144.43 schema:affiliation grid-institutes:grid.411457.2
197 schema:familyName García-Arnés
198 schema:givenName Juan Antonio
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000242144.43
200 rdf:type schema:Person
201 sg:person.010075630453.63 schema:affiliation grid-institutes:None
202 schema:familyName Samaniego
203 schema:givenName M. Luz
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010075630453.63
205 rdf:type schema:Person
206 sg:person.01146401445.26 schema:affiliation grid-institutes:grid.411066.4
207 schema:familyName Cordido
208 schema:givenName Fernando
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146401445.26
210 rdf:type schema:Person
211 sg:person.01207611143.70 schema:affiliation grid-institutes:grid.424551.3
212 schema:familyName Mir
213 schema:givenName Nuria
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207611143.70
215 rdf:type schema:Person
216 sg:person.01271623526.33 schema:affiliation grid-institutes:grid.84393.35
217 schema:familyName Cámara
218 schema:givenName Rosa
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271623526.33
220 rdf:type schema:Person
221 sg:person.01276230215.08 schema:affiliation grid-institutes:grid.73221.35
222 schema:familyName Aller
223 schema:givenName Javier
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276230215.08
225 rdf:type schema:Person
226 sg:person.01336274741.17 schema:affiliation grid-institutes:grid.424551.3
227 schema:familyName Sánchez-Cenizo
228 schema:givenName Laura
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336274741.17
230 rdf:type schema:Person
231 sg:person.0773576715.92 schema:affiliation grid-institutes:grid.411109.c
232 schema:familyName Venegas
233 schema:givenName Eva
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773576715.92
235 rdf:type schema:Person
236 sg:pub.10.1007/bf02599549 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030047977
237 https://doi.org/10.1007/bf02599549
238 rdf:type schema:CreativeWork
239 sg:pub.10.1007/s11102-013-0544-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021018318
240 https://doi.org/10.1007/s11102-013-0544-7
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/s11102-015-0691-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003872791
243 https://doi.org/10.1007/s11102-015-0691-0
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/s11102-016-0754-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040188727
246 https://doi.org/10.1007/s11102-016-0754-x
247 rdf:type schema:CreativeWork
248 sg:pub.10.1007/s12325-015-0266-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033117081
249 https://doi.org/10.1007/s12325-015-0266-5
250 rdf:type schema:CreativeWork
251 sg:pub.10.1007/s40618-017-0614-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083698903
252 https://doi.org/10.1007/s40618-017-0614-1
253 rdf:type schema:CreativeWork
254 sg:pub.10.1023/a:1009965803750 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032354814
255 https://doi.org/10.1023/a:1009965803750
256 rdf:type schema:CreativeWork
257 sg:pub.10.1038/jhh.2015.86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028297512
258 https://doi.org/10.1038/jhh.2015.86
259 rdf:type schema:CreativeWork
260 sg:pub.10.1186/1471-2466-11-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015827023
261 https://doi.org/10.1186/1471-2466-11-6
262 rdf:type schema:CreativeWork
263 grid-institutes:None schema:alternateName TFS Statistical Services, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain
264 schema:name TFS Statistical Services, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain
265 rdf:type schema:Organization
266 grid-institutes:grid.411066.4 schema:alternateName Complejo Hospitalario Universitario A Coruña, As Xubias, 84, 15006, La Coruña, Spain
267 schema:name Complejo Hospitalario Universitario A Coruña, As Xubias, 84, 15006, La Coruña, Spain
268 rdf:type schema:Organization
269 grid-institutes:grid.411109.c schema:alternateName Hospital Universitario Virgen del Rocío, Avenida Manuel Siurot, s/n, 41013, Sevilla, Spain
270 schema:name Hospital Universitario Virgen del Rocío, Avenida Manuel Siurot, s/n, 41013, Sevilla, Spain
271 rdf:type schema:Organization
272 grid-institutes:grid.411457.2 schema:alternateName Hospital Regional Universitario Carlos Haya, Avenida de Carlos Haya, 29006, Málaga, Spain
273 schema:name Hospital Regional Universitario Carlos Haya, Avenida de Carlos Haya, 29006, Málaga, Spain
274 rdf:type schema:Organization
275 grid-institutes:grid.424551.3 schema:alternateName Pfizer S.L.U, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain
276 schema:name Pfizer S.L.U, Avda. Europa, 20B. Parque Empresarial La Moraleja, 28108, Alcobendas, Madrid, Spain
277 rdf:type schema:Organization
278 grid-institutes:grid.73221.35 schema:alternateName Hospital Universitario Puerta de Hierro-Majadahonda, Calle Manuel de Falla, 1, 28222, Majadahonda, Madrid, Spain
279 schema:name Hospital Universitario Puerta de Hierro-Majadahonda, Calle Manuel de Falla, 1, 28222, Majadahonda, Madrid, Spain
280 rdf:type schema:Organization
281 grid-institutes:grid.84393.35 schema:alternateName Hospital Universitario y Politécnico La Fe, Avenida de Fernando Abril Martorell, 106, 46026, Valencia, Spain
282 schema:name Hospital Universitario y Politécnico La Fe, Avenida de Fernando Abril Martorell, 106, 46026, Valencia, Spain
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...